Investing.com - Tonix Pharma reported on Monday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Tonix Pharma announced earnings per share of $-0.6900 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-1.3200 on revenue of $0.00.
Tonix Pharma shares are down 11% from the beginning of the year and are trading at $0.4637 , down-from-52-week-high.
Tonix Pharma shares gained 3.02% in intra-day trade after the report.
Tonix Pharma follows other major Healthcare sector earnings this month
Tonix Pharma's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar